Anal Surgery: Organ and Function Preservation

2016 ◽  
pp. 85-104
Author(s):  
Ann Lowry
Keyword(s):  
Anal Surgery ◽  
Function Preservation ◽  
And Function

Programs of Organ and Function Preservation

2011 ◽  
pp. 327-332
Author(s):  
Jean-Louis Lefebvre
Keyword(s):  
Function Preservation ◽  
And Function

Tissue-conserving surgery for prognosis, treatment, and function preservation

1998 ◽  
Vol 108 (11) ◽  
pp. 1599-1604 ◽  
Author(s):  
David E. Schuller ◽  
Carol M. Bier Laning ◽  
Pramod K. Sharma ◽  
Ronald J. Siegle ◽  
Arthur E. Pellegrini ◽  
...  
Keyword(s):  
Function Preservation ◽  
And Function

Adjuvant therapy for head and neck cancers

2021 ◽  
pp. 977-982
Author(s):  
Charles Kelly
Keyword(s):  
Head And Neck ◽  
Adjuvant Radiotherapy ◽  
Intensity Modulated Radiotherapy ◽  
Transoral Robotic Surgery ◽  
Head And Neck Cancers ◽  
Treatment Model ◽  
Tumour Control ◽  
Primary Surgery ◽  
Function Preservation ◽  
And Function

The non-surgical management of head and neck cancer has changed over the last two decades with more emphasis given now to organ preservation and post-treatment organ function. These two concepts do not necessarily go hand in hand but preserving an organ without preserving its function is pointless. In this period, for some head and neck cancers subsites, for example, oropharynx, the treatment model has moved away from primary surgery followed by planned, adjuvant radiotherapy, to one of primary chemoradiotherapy with the objective of greater organ and function preservation. This change in management strategy may be coming under further review now, with the introduction of transoral robotic surgery (TORS), where the treatment model may revert back to primary surgery with the question raised, whether highly selective TORS followed by highly selective adjuvant radiotherapy using the newer radiation technologies and techniques with intensity-modulated radiotherapy or tomotherapy, with or without chemotherapy might optimize tumour control with minimal long-term morbidity.

Comparative Treatment Outcome in T3N0 Glottic Cancer With and Without Vocal Fold Fixation Receiving Radiation Therapy and Concurrent Low-Dose Intra-Arterial Cisplatin Infusion

2021 ◽  
pp. 000348942110477
Author(s):  
Takeharu Ono ◽  
Norimitsu Tanaka ◽  
Shun-ichi Chitose ◽  
Syuichi Tanoue ◽  
Takashi Kurita ◽  
...  
Keyword(s):  
Vocal Fold ◽  
Locally Advanced ◽  
Survival Rates ◽  
Glottic Cancer ◽  
Cancer Specific Survival ◽  
Laryngeal Function ◽  
Free Survival ◽  
Function Preservation ◽  
Grade 3 ◽  
And Function

Objectives: Selective radiotherapy and concomitant intra-arterial cisplatin infusion (m-RADPLAT) with a lower cisplatin dosage have been performed for organ and function preservation in patients with locally advanced squamous cell carcinoma of the larynx (SCC-L), and results showing a lower rate of adverse events have been reported. This study evaluated the treatment outcomes of patients with T3N0 glottic SCC-L with or without vocal fold fixation (VFF) who were treated with m-RADPLAT. Methods: We retrospectively reviewed the data of 33 patients with T3N0 SCC-L who received m-RADPLAT. Results: The vocal fold in patients with VFF 3 months after completing m-RADPLAT resumed normal movement in 15 patients (83%) and persisted fixation in 3 (17%). The 3-year local control, laryngeal cancer-specific survival, and overall survival rates of patients with or without VFF were 88.9% and 86.7%, 94.1% and 93.3%, and 88.9% and 86.7%, respectively. Additionally, the 3-year freedom from laryngectomy, laryngectomy-free survival, and laryngo-esophageal dysfunction-free survival rates of patients with or without VFF were 94.4% and 86.7%, 88.9% and 73.3%, and 83.3% and 73.3%, respectively. Grade 3 or higher toxicities were observed in all patients: leukopenia in 4 patients (12%), neutropenia in 5 (15%), anemia in 2 (6%), thrombocytopenia in 3 (9%), and mucositis in 2 (6%). Conclusions: This study demonstrated that m-RADPLAT yielded VFF improvement and a favorable survival while maintaining laryngeal function not only in patients with T3N0 glottic SCC-L without VFF but also in patients with VFF.

Brachytherapy and function preservation in the localized management of soft tissue sarcomas of the extremity

1993 ◽  
Vol 3 (4) ◽  
pp. 260-269 ◽  
Author(s):  
Louis B. Harrison ◽  
Michael J. Zelefsky ◽  
John G. Armstrong ◽  
Karen D. Schupak ◽  
Murray F. Brennan
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcomas ◽  
Function Preservation ◽  
And Function

scholarly journals Retinal structure and function preservation by polysaccharides of wolfberry in a mouse model of retinal degeneration

2014 ◽  
Vol 4 (1) ◽  
Author(s):  
Ke Wang ◽  
Jia Xiao ◽  
Bo Peng ◽  
Feiyue Xing ◽  
Kwok-Fai So ◽  
...  
Keyword(s):  
Mouse Model ◽  
Retinal Degeneration ◽  
Structure And Function ◽  
Function Preservation ◽  
Retinal Structure ◽  
And Function

Programs of Organ and Function Preservation

2016 ◽  
pp. 569-574
Author(s):  
Jean Louis Lefebvre
Keyword(s):  
Function Preservation ◽  
And Function
Sign in / Sign up

Export Citation Format

Share Document